Status:
WITHDRAWN
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
Lead Sponsor:
Click Therapeutics, Inc.
Conditions:
Nicotine Addiction
Drug Addiction
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is evaluating the efficacy of Treatment A for short-term smoking cessation through a blinded randomized controlled trial (RCT) vs.Treatment B.
Detailed Description
The overarching study aim is to recruit a population of current smokers who are motivated to quit with the assistance of a mobile solution, enroll them into a study testing apps to help them quit, and...
Eligibility Criteria
Inclusion
- Age 18 to 65
- Smokes at least 5 cigarettes daily
- Is interested in quitting in the next 30 days
- Owns an iPhone with iOS 9 or higher or Android with OS 4.1 or higher
- Willing and able to receive SMS text messages
- Able to comprehend the English-language and the informed consent form
- Lives in the United States
- One half of the study sample will be recruited from the general population of smokers via social media advertisements
- One half of the study sample will be recruited via mail from a Magellan Behavioral Health value-based care network
Exclusion
- Prior use of Clickotine or QuitGuide
- Current use of pharmacotherapy for smoking cessation or nicotine replacement therapy (NRT)
Key Trial Info
Start Date :
October 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05440721
Start Date
October 25 2018
End Date
August 1 2022
Last Update
July 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Click Therapeutics
New York, New York, United States, 10013